KOAN (Resonate Blends) Days Payable : 467.91 (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Resonate Blends Days Payable?

Resonate Blends's average Accounts Payable for the three months ended in Sep. 2024 was $0.92 Mil. Resonate Blends's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.18 Mil. Hence, Resonate Blends's Days Payable for the three months ended in Sep. 2024 was 467.91.

The historical rank and industry rank for Resonate Blends's Days Payable or its related term are showing as below:

KOAN' s Days Payable Range Over the Past 10 Years
Min: 400.55 Med: 1224.67 Max: 3976.58
Current: 450.25

During the past 13 years, Resonate Blends's highest Days Payable was 3976.58. The lowest was 400.55. And the median was 1224.67.

KOAN's Days Payable is ranked better than
93.59% of 952 companies
in the Drug Manufacturers industry
Industry Median: 85.205 vs KOAN: 450.25

Resonate Blends's Days Payable increased from Sep. 2023 (0.00) to Sep. 2024 (467.91). It may suggest that Resonate Blends delayed paying its suppliers.

Resonate Blends Days Payable Historical Data

The historical data trend for Resonate Blends's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Resonate Blends Days Payable Chart

Resonate Blends Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

3,976.58

2,828.75

1,224.67

Resonate Blends Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	364.10	1,998.67	313.89	467.91

Competitive Comparison of Resonate Blends's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Resonate Blends's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Resonate Blends's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Resonate Blends's Days Payable distribution charts can be found below:

* The bar in red indicates where Resonate Blends's Days Payable falls into.

Resonate Blends Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Resonate Blends's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.32	+	0.445)	/	2 )	/	0.114	*	365
=	0.3825					/	0.114	*	365
=	1,224.67

Resonate Blends's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (0.917	+	0.929)	/	2 )	/	0.18	*	365 / 4
=	0.923					/	0.18	*	365 / 4
=	467.91

Resonate Blends Days Payable Related Terms

Thank you for viewing the detailed overview of Resonate Blends's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Resonate Blends Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Resonate Blends Inc (OTCPK:KOAN) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Marine Plaza, Suite 305A, North Bergen, NJ, USA, 04047

Website

https://www.resonateblends.com

Resonate Blends Inc engages in the discovery, development and marketing of products designed to better mankind. The company believes It is positioning its company as a leader in the field of Regenerative Medicine defined by the National Institute of Health using nutritionally designed products. Intended products are to be marketed under third-party label exemptions. It is focusing its current efforts on marketing licensed patent-pending natural stem cell mobilizing agents capable of enhancing each individual's ability to mobilize their adult stem cells from their bone marrow.

Executives

Richard Hoge	10 percent owner	C/O JIM KEARNEY, 760 SW 9TH AVE. STE 3000, PORTLAND OR 97205
Pamela Kerwin	officer: Chief Operating Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
Geoffrey Selzer	director, officer: Chief Executive Officer	26565 AGOURA ROAD, SUITE 200, CALABASAS CA 91302
David Thomas Thielen	10 percent owner, officer: COO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Nick Allen Miniello	10 percent owner, officer: VP of Sales	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Wais Asefi	director, 10 percent owner, officer: CEO	1940 CONTRA COSTA BLVD., PLEASANT HILL CA 94523
Sterling John M Iii	director
Gregory Oliver Sargent	10 percent owner	1609 FAIRFIELD BEACH ROAD, FAIRFIELD CT 06824
Steven Richard Deerwester	officer: Vice President	3125 DARTMOUTH PLACE, CUMMING GA 30041
David G Kane	other: Controller	50 JOE LEE DRIVE, SHARPSBURG GA 30277
I Sigmund Mosley	director	945 E PACES FERRY RD, SUITE 2450, ATLANTA GA 30326
Vincent J Dooley	director	2859 PACES FERRY ROAD, SUITE 1000, ATLANTA GA 30339
Spencer John N Jr	director	2859 PACES FERRY RD, STE 1000, ATLANTA GA 30339
Marsha K Calfee	officer: VP of Product Development
Jeffrey Longoria	officer: VP of Sales